DadFinStart your free week
DadFin › Stocks › Financial Services › AJG

Arthur J. Gallagher & Co. (AJG) stock score

Financial Services · Insurance Brokers · United States

$232.70 ▼ -0.58% today

55.2
Dad Score, out of 100
middling

Arthur J. Gallagher & Co. (AJG) is a Insurance Brokers company in the Financial Services sector, listed in the United States. On DadFin's weekly run it scores 55.2 out of 100 on the Dad Score, a middling reading that places the business ahead of 55% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Financial Services it ranks #696 of 1,228. Its strongest axes are quality, growth and conviction; its weakest are valuation and price action.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Below average
Quality
Strong
Growth
Above average
Price action
Below average
Risk
Average
Conviction
Strong
Liquidity
Strong
Macro
Strong

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)37.4×
P/E (forward)15.2×
Dividend yield1.16%
Return on capital6.6%
Operating margin19.2%
Revenue growth (YoY)+20.7%
FCF yield2.6%
Net debt / EBITDA2.97×
Piotroski F-Score6 / 9
52-week change-26.0%
Market cap$58.0B
Next earningsOct 29, 2026

What subscribers see on AJG

Start your free weekSubscriber? Open the full research →

Insurance Brokers peers

StockCompanyDad ScoreBandMarket cap
MRSHMarsh & McLennan Companies, Inc.97.7strong$81.2B
AONAon plc76.0good$57.2B
WTWWillis Towers Watson Public Limite35.5weak$26.8B
BROBrown & Brown, Inc.66.7middling$20.0B
ERIEErie Indemnity Company55.8middling$11.6B
RYANRyan Specialty Holdings, Inc.49.3middling$9.7B
ARXAccelerant Holdings9.1poor$4.3B
CRVLCorVel Corporation79.7good$3.8B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.